Clearmind Medicine reports positive permeation results for intranasal MEAI formulation study
CMND•Intranasal MEAI study shows positive permeation results
Clearmind Medicine reported new permeation study results for its intranasal MEAI program, with findings already presented in the announcement.
The study supported that the mucoadhesive nasal formulation can extend nasal retention without materially reducing drug delivery performance.
Results underpin continued development of intranasal MEAI as a differentiated candidate for alcohol use disorder, weight management, obesity, and metabolic conditions.
